Skip to content

A study to compare the effectivity of tila taila snehana and eranda nirgundi sarvang swedan with regular sutika chikitsa in sutikavashtha

A comparative clinical trial to evalute efficcacy beween tila taila snehana and erand nirgundi sarvang swedana with PNC chikitsa in sutikavastha

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/037010
Enrollment
120
Registered
2021-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O909- Complication of the puerperium, unspecified Health Condition 2: O920- Retracted nipple associated with pregnancy, the puerperium, and lactation

Interventions

Intervention1: Tila taila and Eranda Nirgundi patra: 80ml Tila taila will be used for snehana for 4 days And Erand Nirgundi will be used for sarvang swedan Control Intervention1: Regular PNC chikitsa

Sponsors

Dr Priyanka Sunil Chaudhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PRIMI WITH FULL TERM NORMAL DELIVERY

Exclusion criteria

Exclusion criteria: DELIVERED WOMEN WITH OTHER SYSTEMIC DISEASES LIKE DM, HTN, BA, SKIN ISEASES LSCS ANAEMIA

Design outcomes

Primary

MeasureTime frame
To study the efficacy of tila taila snehan and Eranda Nirgundi patra sarvang swedan in sutika awasthaTimepoint: To study the efficacy of tila taila snehan and Eranda Nirgundi patra sarvang swedan in sutika awastha for 8 days after delivery

Secondary

MeasureTime frame
To study the efficacy of tila taila snehan and Eranda Nirgundi patra sarvang swedan in sutika awasthaTimepoint: 8 days

Countries

India

Contacts

Public ContactDR MANDA S GHORPADE

SUMATIBHAI SHAH AYURVEA COLLEGE

mandaghorpade@yahoo.com9822007570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026